Skip to main content

Table 1 Checklist of baseline and follow-up visits of patients enrolled in the Base-NAFLD study

From: Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study

 

Visit 1

(Baseline)

Visit 2

(3-month intervals)

Visit 3

(6-month intervals)

Visit 4

(1-year intervals)

Visit 5

(2-year intervals)

Demographic data

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

Disease history and medication usage

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

Surgical information

â—Ź

âś—

âś—

âś—

âś—

Weight loss

âś—

â—Ź

â—Ź

â—Ź

â—Ź

Routine blood tests

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

HbA1c

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

OGTT

â—Ź

âś—

âś—

â—‹

âś—

FBG

âś—

â—Ź

â—‹

â—Ź

âś—

â—Ź

Fasting insulin and fasting C-peptide

âś—

â—‹

â—‹

â—Ź

â—‹

Biochemical examination

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

Thyroid function

â—Ź

â—‹

â—‹

â—Ź

â—Ź

Serum iron and TIBC

â—Ź

â—Ź

â—‹

â—Ź

â—Ź

Ferritin and folate and Vitamin B12

â—Ź

â—Ź

â—‹

â—Ź

â—Ź

AFP

â—Ź

âś—

âś—

âś—

â—Ź

Coagulation function

â—Ź

â—‹

âś—

â—Ź

â—Ź

Gastroscopy

â—Ź

âś—

âś—

â—‹

â—‹

C13 breath tests

â—Ź

âś—

âś—

â—‹

â—‹

Abdominal ultrasonography

â—Ź

â—Ź

â—‹

â—‹

â—‹

Lower extremity vascular ultrasound

â—Ź

âś—

âś—

â—‹

â—‹

Abdominal MRI

â—Ź

â—Ź

â—Ź

â—Ź

â—Ź

Liver biopsy

â—Ź

âś—

âś—

â—Ź

âś—

Adverse events

âś—

â—Ź

â—Ź

â—Ź

â—Ź

  1. Base-NAFLD, Bariatric Surgery for Non-alcoholic Fatty Liver Diseases in Individuals with Obesity; HbA1c, glycosylated haemoglobin; OGTT, oral glucose tolerance test; FBG, fasting blood glucose; TIBC, total iron-binding capacity; AFP, alpha-fetoprotein
  2. â—Ź: Mandatory; â—‹: Optional; âś—: Not required